Clinical Trial Update: Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update reports efficacy results for besifloxacin ophthalmic suspension in the treatment of bacterial conjunctivitis, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• Besifloxacin ophthalmic suspension (besifloxacin)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Bacterial Conjunctivitis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-03-29